Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Aug 25;289(6443):468–469. doi: 10.1136/bmj.289.6443.468

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

D Kerle, G Williams, H Ware, S R Bloom
PMCID: PMC1442548  PMID: 6235888

Full text

PDF
468

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. M., O'Shea J. P., Mashiter K., Williams G., Bloom S. R. Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. Br Med J (Clin Res Ed) 1983 May 21;286(6378):1607–1609. doi: 10.1136/bmj.286.6378.1607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. EMMETT J. L., GREENE L. F., PAPANTONIOU A. Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies. J Urol. 1960 Apr;83:471–484. doi: 10.1016/S0022-5347(17)65741-0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES